These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31712163)

  • 41. TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.
    Sun Y; Schaar A; Sukumaran P; Dhasarathy A; Singh BB
    Mol Carcinog; 2018 Jun; 57(6):752-761. PubMed ID: 29500887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
    Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
    Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
    Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP
    Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
    Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
    J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
    Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
    Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
    Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
    Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.
    Cordonnier T; Bishop JL; Shiota M; Nip KM; Thaper D; Vahid S; Heroux D; Gleave M; Zoubeidi A
    Int J Cancer; 2015 Mar; 136(6):E496-507. PubMed ID: 25130271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
    Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
    Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
    Shi ZM; Wang L; Shen H; Jiang CF; Ge X; Li DM; Wen YY; Sun HR; Pan MH; Li W; Shu YQ; Liu LZ; Peiper SC; He J; Jiang BH
    Oncogene; 2017 May; 36(18):2577-2588. PubMed ID: 28192397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway.
    Tong J; Shen Y; Zhang Z; Hu Y; Zhang X; Han L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of LPS-induced epithelial-mesenchymal transition by aqueous extracts of Prunella vulgaris through inhibition of the NF-κB/Snail signaling pathway and regulation of EMT-related protein expression.
    Cho IH; Jang EH; Hong D; Jung B; Park MJ; Kim JH
    Oncol Rep; 2015 Nov; 34(5):2445-50. PubMed ID: 26324883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
    Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H
    Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling.
    Song Y; Chen Y; Li Y; Lyu X; Cui J; Cheng Y; Zheng T; Zhao L; Zhao G
    Biomed Res Int; 2019; 2019():1321973. PubMed ID: 31119150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.